Medolife Rx Completes Batch Production of Escozine® for FDA Submission
BURBANK, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary …